<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-02-01" modified="2017-11-22" version="190">
<accession>P19784</accession>
<name>CSK22_HUMAN</name>
<protein>
<recommendedName>
<fullName>Casein kinase II subunit alpha'</fullName>
<shortName>CK II alpha'</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">CSNK2A2</name>
<name type="synonym">CK2A2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Biochemistry" volume="29" first="8436" last="8447">
<title>Isolation and characterization of human cDNA clones encoding the alpha and the alpha' subunits of casein kinase II.</title>
<authorList>
<person name="Lozeman F.J."/>
<person name="Litchfield D.W."/>
<person name="Piening C."/>
<person name="Takio K."/>
<person name="Walsh K.A."/>
<person name="Krebs E.G."/>
</authorList>
<dbReference type="PubMed" id="2174700"/>
<dbReference type="DOI" id="10.1021/bi00488a034"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="283" last="292">
<title>A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.</title>
<authorList>
<person name="Keller D.M."/>
<person name="Zeng X."/>
<person name="Wang Y."/>
<person name="Zhang Q.H."/>
<person name="Kapoor M."/>
<person name="Shu H."/>
<person name="Goodman R."/>
<person name="Lozano G."/>
<person name="Zhao Y."/>
<person name="Lu H."/>
</authorList>
<dbReference type="PubMed" id="11239457"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00176-9"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SSRP1 AND SUPT16H</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="6994" last="7005">
<title>Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells.</title>
<authorList>
<person name="Sayed M."/>
<person name="Pelech S."/>
<person name="Wong C."/>
<person name="Marotta A."/>
<person name="Salh B."/>
</authorList>
<dbReference type="PubMed" id="11704824"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204894"/>
</citation>
<scope>FUNCTION IN CELL CYCLE</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="50206" last="50213">
<title>p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.</title>
<authorList>
<person name="Keller D.M."/>
<person name="Lu H."/>
</authorList>
<dbReference type="PubMed" id="12393879"/>
<dbReference type="DOI" id="10.1074/jbc.M209820200"/>
</citation>
<scope>INTERACTION WITH SSRP1 AND SUPT16H</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="3532" last="3542">
<title>Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8.</title>
<authorList>
<person name="Shin S."/>
<person name="Lee Y."/>
<person name="Kim W."/>
<person name="Ko H."/>
<person name="Choi H."/>
<person name="Kim K."/>
</authorList>
<dbReference type="PubMed" id="16193064"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600827"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="FASEB J." volume="17" first="349" last="368">
<title>One-thousand-and-one substrates of protein kinase CK2?</title>
<authorList>
<person name="Meggio F."/>
<person name="Pinna L.A."/>
</authorList>
<dbReference type="PubMed" id="12631575"/>
<dbReference type="DOI" id="10.1096/fj.02-0473rev"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-21 AND SER-288</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Cell. Mol. Life Sci." volume="66" first="1800" last="1816">
<title>Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.</title>
<authorList>
<person name="Niefind K."/>
<person name="Raaf J."/>
<person name="Issinger O.G."/>
</authorList>
<dbReference type="PubMed" id="19387553"/>
<dbReference type="DOI" id="10.1007/s00018-009-9149-8"/>
</citation>
<scope>REVIEW ON STRUCTURE</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Cell. Mol. Life Sci." volume="66" first="1817" last="1829">
<title>Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival.</title>
<authorList>
<person name="St-Denis N.A."/>
<person name="Litchfield D.W."/>
</authorList>
<dbReference type="PubMed" id="19387552"/>
<dbReference type="DOI" id="10.1007/s00018-009-9150-2"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Cell. Mol. Life Sci." volume="66" first="1830" last="1839">
<title>Protein kinase CK2 in health and disease: Cellular functions of protein kinase CK2: a dynamic affair.</title>
<authorList>
<person name="Filhol O."/>
<person name="Cochet C."/>
</authorList>
<dbReference type="PubMed" id="19387551"/>
<dbReference type="DOI" id="10.1007/s00018-009-9151-1"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Cell. Mol. Life Sci." volume="66" first="1840" last="1849">
<title>Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery.</title>
<authorList>
<person name="Miyata Y."/>
</authorList>
<dbReference type="PubMed" id="19387550"/>
<dbReference type="DOI" id="10.1007/s00018-009-9152-0"/>
</citation>
<scope>REVIEW ON FUNCTION IN REGULATION OF HSP90</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Cell. Mol. Life Sci." volume="66" first="1850" last="1857">
<title>Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.</title>
<authorList>
<person name="Dominguez I."/>
<person name="Sonenshein G.E."/>
<person name="Seldin D.C."/>
</authorList>
<dbReference type="PubMed" id="19387549"/>
<dbReference type="DOI" id="10.1007/s00018-009-9153-z"/>
</citation>
<scope>REVIEW ON FUNCTION IN WNT SIGNALING</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-13; SER-18; SER-21 AND SER-288</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-97</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Acta Crystallogr. F" volume="65" first="75" last="79">
<title>Structure of human protein kinase CK2 alpha 2 with a potent indazole-derivative inhibitor.</title>
<authorList>
<person name="Nakaniwa T."/>
<person name="Kinoshita T."/>
<person name="Sekiguchi Y."/>
<person name="Tada T."/>
<person name="Nakanishi I."/>
<person name="Kitaura K."/>
<person name="Suzuki Y."/>
<person name="Ohno H."/>
<person name="Hirasawa A."/>
<person name="Tsujimoto G."/>
</authorList>
<dbReference type="PubMed" id="19193990"/>
<dbReference type="DOI" id="10.1107/S1744309108043194"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 1-334 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="J. Mol. Biol." volume="407" first="1" last="12">
<title>Structure of the human protein kinase CK2 catalytic subunit CK2alpha' and interaction thermodynamics with the regulatory subunit CK2beta.</title>
<authorList>
<person name="Bischoff N."/>
<person name="Olsen B."/>
<person name="Raaf J."/>
<person name="Bretner M."/>
<person name="Issinger O.G."/>
<person name="Niefind K."/>
</authorList>
<dbReference type="PubMed" id="21241709"/>
<dbReference type="DOI" id="10.1016/j.jmb.2011.01.020"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS)</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ALA-188</scope>
</reference>
<comment type="function">
<text evidence="10 11 13">Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="7">Constitutively active protein kinase whose activity is not directly affected by phosphorylation. Seems to be regulated by level of expression and localization (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="10 12 15">Heterotetramer composed of two catalytic subunits (alpha chain and/or alpha' chain) and two regulatory subunits (beta chains). The tetramer can exist as a combination of 2 alpha/2 beta, 2 alpha'/2 beta or 1 alpha/1 alpha'/2 beta subunits. Also part of a CK2-SPT16-SSRP1 complex composed of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B, which forms following UV irradiation. Interacts with RNPS1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347451"/>
<interactant intactId="EBI-347804">
<id>P68400</id>
<label>CSNK2A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347451"/>
<interactant intactId="EBI-348169">
<id>P67870</id>
<label>CSNK2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347451"/>
<interactant intactId="EBI-717170">
<id>O60282</id>
<label>KIF5C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347451"/>
<interactant intactId="EBI-725997">
<id>Q8WV44</id>
<label>TRIM41</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="miscellaneous">
<text>Can use both ATP and GTP as phosphoryl donors. Phosphorylation by casein kinase 2 has been estimated to represent up to one quarter of the eukaryotic phosphoproteome.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CK2 subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="M55268">
<property type="protein sequence ID" value="AAA51548.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008812">
<property type="protein sequence ID" value="AAH08812.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10794.1"/>
<dbReference type="PIR" id="B35838">
<property type="entry name" value="B35838"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001887.1">
<property type="nucleotide sequence ID" value="NM_001896.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.82201"/>
<dbReference type="PDB" id="3E3B">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="X=1-334"/>
</dbReference>
<dbReference type="PDB" id="3OFM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-350"/>
</dbReference>
<dbReference type="PDB" id="3U87">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=327-350"/>
</dbReference>
<dbReference type="PDB" id="5M4U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A=1-350"/>
</dbReference>
<dbReference type="PDB" id="5M56">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.24"/>
<property type="chains" value="A/B=1-350"/>
</dbReference>
<dbReference type="PDBsum" id="3E3B"/>
<dbReference type="PDBsum" id="3OFM"/>
<dbReference type="PDBsum" id="3U87"/>
<dbReference type="PDBsum" id="5M4U"/>
<dbReference type="PDBsum" id="5M56"/>
<dbReference type="ProteinModelPortal" id="P19784"/>
<dbReference type="SMR" id="P19784"/>
<dbReference type="BioGrid" id="107842">
<property type="interactions" value="225"/>
</dbReference>
<dbReference type="CORUM" id="P19784"/>
<dbReference type="DIP" id="DIP-318N"/>
<dbReference type="IntAct" id="P19784">
<property type="interactions" value="155"/>
</dbReference>
<dbReference type="MINT" id="MINT-5004107"/>
<dbReference type="STRING" id="9606.ENSP00000262506"/>
<dbReference type="BindingDB" id="P19784"/>
<dbReference type="ChEMBL" id="CHEMBL4070"/>
<dbReference type="DrugBank" id="DB07546">
<property type="generic name" value="[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1550"/>
<dbReference type="iPTMnet" id="P19784"/>
<dbReference type="PhosphoSitePlus" id="P19784"/>
<dbReference type="BioMuta" id="CSNK2A2"/>
<dbReference type="DMDM" id="125266"/>
<dbReference type="SWISS-2DPAGE" id="P19784"/>
<dbReference type="EPD" id="P19784"/>
<dbReference type="MaxQB" id="P19784"/>
<dbReference type="PaxDb" id="P19784"/>
<dbReference type="PeptideAtlas" id="P19784"/>
<dbReference type="PRIDE" id="P19784"/>
<dbReference type="DNASU" id="1459"/>
<dbReference type="Ensembl" id="ENST00000262506">
<property type="protein sequence ID" value="ENSP00000262506"/>
<property type="gene ID" value="ENSG00000070770"/>
</dbReference>
<dbReference type="GeneID" id="1459"/>
<dbReference type="KEGG" id="hsa:1459"/>
<dbReference type="UCSC" id="uc002enc.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1459"/>
<dbReference type="DisGeNET" id="1459"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000070770.8"/>
<dbReference type="GeneCards" id="CSNK2A2"/>
<dbReference type="HGNC" id="HGNC:2459">
<property type="gene designation" value="CSNK2A2"/>
</dbReference>
<dbReference type="HPA" id="HPA077719"/>
<dbReference type="MIM" id="115442">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P19784"/>
<dbReference type="OpenTargets" id="ENSG00000070770"/>
<dbReference type="PharmGKB" id="PA26959"/>
<dbReference type="eggNOG" id="KOG0668">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNPP">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000004215"/>
<dbReference type="HOGENOM" id="HOG000233021"/>
<dbReference type="HOVERGEN" id="HBG107282"/>
<dbReference type="KO" id="K03097"/>
<dbReference type="OMA" id="LQQYDYS"/>
<dbReference type="OrthoDB" id="EOG091G0AZY"/>
<dbReference type="PhylomeDB" id="P19784"/>
<dbReference type="TreeFam" id="TF300483"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1483191">
<property type="pathway name" value="Synthesis of PC"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201688">
<property type="pathway name" value="WNT mediated activation of DVL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2514853">
<property type="pathway name" value="Condensation of Prometaphase Chromosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6814122">
<property type="pathway name" value="Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8934903">
<property type="pathway name" value="Receptor Mediated Mitophagy"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939243">
<property type="pathway name" value="RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8948751">
<property type="pathway name" value="Regulation of PTEN stability and activity"/>
</dbReference>
<dbReference type="SignaLink" id="P19784"/>
<dbReference type="SIGNOR" id="P19784"/>
<dbReference type="ChiTaRS" id="CSNK2A2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P19784"/>
<dbReference type="GeneWiki" id="CSNK2A2"/>
<dbReference type="GenomeRNAi" id="1459"/>
<dbReference type="PRO" id="PR:P19784"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000070770"/>
<dbReference type="CleanEx" id="HS_CSNK2A2"/>
<dbReference type="ExpressionAtlas" id="P19784">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P19784">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0001669">
<property type="term" value="C:acrosomal vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0021987">
<property type="term" value="P:cerebral cortex development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016236">
<property type="term" value="P:macroautophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006656">
<property type="term" value="P:phosphatidylcholine biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1903955">
<property type="term" value="P:positive regulation of protein targeting to mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006457">
<property type="term" value="P:protein folding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1903146">
<property type="term" value="P:regulation of autophagy of mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905818">
<property type="term" value="P:regulation of chromosome separation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="chain" description="Casein kinase II subunit alpha'" id="PRO_0000085891">
<location>
<begin position="1"/>
<end position="350"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="8">
<location>
<begin position="40"/>
<end position="325"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="8">
<location>
<begin position="46"/>
<end position="54"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="8 9">
<location>
<position position="157"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="8">
<location>
<position position="69"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 6">
<location>
<position position="18"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="5">
<location>
<position position="97"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4">
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55911801." id="VAR_040416" evidence="14">
<original>E</original>
<variation>A</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="11"/>
<end position="13"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="14"/>
<end position="16"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="17"/>
<end position="19"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="22"/>
<end position="25"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="27"/>
<end position="29"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="40"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="59"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="60"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="64"/>
<end position="71"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="76"/>
<end position="88"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="98"/>
<end position="103"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="110"/>
<end position="115"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="122"/>
<end position="125"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="126"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="131"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="160"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="163"/>
<end position="166"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="167"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="196"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="201"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="213"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="231"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="239"/>
<end position="250"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="252"/>
<end position="261"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="270"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="282"/>
<end position="285"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="291"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="296"/>
<end position="305"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="316"/>
<end position="320"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="326"/>
<end position="331"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OFM"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5M56"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11239457"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11704824"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12393879"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16193064"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19193990"/>
</source>
</evidence>
<sequence length="350" mass="41213" checksum="3ECB92F6BD3DD7F1" modified="1991-02-01" version="1">
MPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINI
TNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNT
DFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLA
EFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNY
DQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALD
LLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPCADNAVLSSGLTAAR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>